Purpose
Lubricant
Exovisse Preservative-free Artificial Tears Liquid
FDA Label NDC 87106-005
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Yd Bio Usa, Inc. for the product Exovisse Preservative-free Artificial Tears (NDC 87106-005). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding purpose, active ingredient, indications, warnings, do not use, when using, stop use and ask a doctor if you experience any of the following:, keep out of reach of children., and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Active Ingredient
Hypromellose 0.2%
Indications
Uses
For the temporary relief of burning and irritation due to dryness of the eye
For use as a protectant against further irritation
Warnings
For external use only
Do Not Use
If this solution changes color or becomes cloudy
If you are sensitive to any ingredient in this product
When Using
Do not touch tip of container to any surface to avoid contamination
Replace cap after each use
Do not use if bottle seal is broken or missing
Stop Use And Ask A Doctor If You Experience Any Of The Following:
Eye pain
Changes in vision
Continued redness or irritation of the eye
Condition worsens or persists for more than 72 hours
Keep Out Of Reach Of Children.
If swallowed, get medical help or contact a Poison Control Center right away.
Other Information
Store at room temperature
Use before expiration date marked on container
Retain this carton for future reference
Directions
Shake well before using
Instill 1-2 drops in the affected eye(s) as needed
Questions?
visit www.exovissecare.com
Inactive Ingredients
Sodium chloride, poloxamer, boric acid, sodium borate decahydrate, water for injection.
* Please review the disclaimer below.
